New Zealand markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
61.43-2.34 (-3.67%)
At close: 04:00PM EDT
61.43 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.34B
Enterprise value 1.41B
Trailing P/E 39.61
Forward P/E 15.04
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.33
Price/book (mrq)2.96
Enterprise value/revenue 2.72
Enterprise value/EBITDA 11.12

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 338.72%
S&P500 52-week change 326.36%
52-week high 370.81
52-week low 344.27
50-day moving average 366.85
200-day moving average 359.77

Share statistics

Avg vol (3-month) 3160.13k
Avg vol (10-day) 3160.84k
Shares outstanding 520.96M
Implied shares outstanding 620.96M
Float 815.63M
% held by insiders 111.21%
% held by institutions 177.89%
Shares short (30 Apr 2024) 4229.92k
Short ratio (30 Apr 2024) 41.73
Short % of float (30 Apr 2024) 41.42%
Short % of shares outstanding (30 Apr 2024) 41.10%
Shares short (prior month 28 Mar 2024) 4197.03k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 318 Jul 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.87%
Operating margin (ttm)10.95%

Management effectiveness

Return on assets (ttm)3.91%
Return on equity (ttm)8.71%

Income statement

Revenue (ttm)517.46M
Revenue per share (ttm)27.70
Quarterly revenue growth (yoy)28.70%
Gross profit (ttm)N/A
EBITDA 112.38M
Net income avi to common (ttm)30.55M
Diluted EPS (ttm)1.61
Quarterly earnings growth (yoy)1,165.30%

Balance sheet

Total cash (mrq)238.25M
Total cash per share (mrq)12.28
Total debt (mrq)290.51M
Total debt/equity (mrq)60.93%
Current ratio (mrq)3.95
Book value per share (mrq)23.26

Cash flow statement

Operating cash flow (ttm)115.8M
Levered free cash flow (ttm)79.33M